title: Commentary on "pANCA positivity predicts lower clinical response to infliximab therapy among patients with IBD".
authors.affiliation: From the Department of Colorectal Surgery, Wye Valley Hospitals NHS Trust, Hereford, United Kingdom.
authors.forename: Edmund
authors.initials: E
authors.lastname: Leung
mesh_terms: D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D019268:Antibodies, Antineutrophil Cytoplasmic / Q000097:blood*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D006801:Humans; D015212:Inflammatory Bowel Diseases / Q000188:drug therapy*; D000069285:Infliximab
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D019268:Antibodies, Antineutrophil Cytoplasmic; D000911:Antibodies, Monoclonal; D000069285:Infliximab